Elevated 1,25-Dihydroxyvitamin D Levels
- 1 June 1982
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 142 (6) , 1206-1207
- https://doi.org/10.1001/archinte.1982.00340190162027
Abstract
• It is generally agreed that the kidneys are the only site of 1-hydroxylation of vitamin D and that the abnormal calcium metabolism in sarcoidosis is caused by increased production of 1,25-dihydroxyvitamin D (1,25-[OH]2D). We describe a patient with sarcoidosis with hypercalcemic nephropathy and end-stage renal disease undergoing long-term maintenance hemodialysis who was initially seen with hypercalcemia and elevated serum levels of 1,25-(OH)2D. Prednisone administration resulted in decreased serum calcium and 1,25-(OH)2D levels. These results confirm the recent evidence for extrarenal production of 1,25-(OH)2D in sarcoidosis and illustrate the importance of altered vitamin D metabolism in the development of hypercalcemia in sarcoidosis. (Arch Intern Med 1982;142:1206-1207)This publication has 5 references indexed in Scilit:
- The control of 25-hydroxyvitamin D metabolism by inorganic phosphorusPublished by Elsevier ,2004
- Unique Biosynthesis by Kidney of a Biologically Active Vitamin D MetaboliteNature, 1970
- On the abnormal calcium absorption in sarcoidosisThe American Journal of Medicine, 1964
- Renal insufficiency, renal calculi and nephrocalcinosis in sarcoidosis: Report of eight casesThe American Journal of Medicine, 1956
- Renal complications of sarcoidosis and their relationship to hypercalcemiaThe American Journal of Medicine, 1953